Alphatec Holdings Hits Day High with 16.29% Surge in Stock Price

Alphatec Holdings, Inc., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a significant surge in its stock price, gaining 16.29% on October 31, 2025. The stock reached an intraday high of USD 20.14, reflecting strong performance metrics compared to the broader market.
Over the past week, Alphatec has outperformed the S&P 500, with a weekly gain of 17.88% versus the index's 0.71%. The company's one-month performance stands at an impressive 35.93%, while its year-to-date increase is 106.86%, significantly surpassing the S&P 500's 16.3% gain.

Despite these positive trends, Alphatec's financials indicate some caution. The company has reported a negative EBITDA and a return on equity of -272.15%, suggesting challenges in profitability. Additionally, the stock's price-to-book ratio is notably high at 51.67, indicating a premium valuation relative to its book value. As Alphatec continues to navigate its market position, these financial indicators will be crucial for understanding its ongoing performance.